BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32297029)

  • 21. 3p-C-NETA: A versatile and effective chelator for development of Al
    Ahenkorah S; Murce E; Cawthorne C; Ketchemen JP; Deroose CM; Cardinaels T; Seimbille Y; Fonge H; Gsell W; Bormans G; Ooms M; Cleeren F
    Theranostics; 2022; 12(13):5971-5985. PubMed ID: 35966589
    [No Abstract]   [Full Text] [Related]  

  • 22. Intraindividual comparison of 68Ga-DOTA-TATE and 18F-DOPA PET in patients with well-differentiated metastatic neuroendocrine tumours.
    Haug A; Auernhammer CJ; Wängler B; Tiling R; Schmidt G; Göke B; Bartenstein P; Pöpperl G
    Eur J Nucl Med Mol Imaging; 2009 May; 36(5):765-70. PubMed ID: 19137293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preclinical evaluation of a dual sstr2 and integrin α
    Liu B; Zhang Z; Wang H; Yao S
    Bioorg Med Chem; 2019 Nov; 27(21):115094. PubMed ID: 31540828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation and comparison of Ga-68 DOTA-TATE and Ga-68 DOTA-NOC PET/CT imaging in well-differentiated thyroid cancer.
    Ocak M; Demirci E; Kabasakal L; Aygun A; Tutar RO; Araman A; Kanmaz B
    Nucl Med Commun; 2013 Nov; 34(11):1084-9. PubMed ID: 23939265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Lung Cancer and Neuroendocrine Neoplasm in a Single Scan by Targeting Both Somatostatin Receptor and Integrin αvβ3.
    Zheng Y; Wang H; Tan H; Cui X; Yao S; Zang J; Zhang L; Zhu Z
    Clin Nucl Med; 2019 Sep; 44(9):687-694. PubMed ID: 31274560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Semiquantitative analysis and characterization of physiological biodistribution of (68)Ga-DOTA-TATE PET/CT.
    Kunikowska J; Królicki L; Pawlak D; Zerizer I; Mikołajczak R
    Clin Nucl Med; 2012 Nov; 37(11):1052-7. PubMed ID: 22996234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationships between uptake of [
    Stenvall A; Gustafsson J; Larsson E; Roth D; Sundlöv A; Jönsson L; Hindorf C; Ohlsson T; Sjögreen Gleisner K
    EJNMMI Res; 2022 Dec; 12(1):75. PubMed ID: 36534192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detailed evaluation on the effect of metal ion impurities on complexation of generator eluted 68Ga with different bifunctional chelators.
    Chakravarty R; Chakraborty S; Dash A; Pillai MR
    Nucl Med Biol; 2013 Feb; 40(2):197-205. PubMed ID: 23218795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PET/CT With 68Ga-DOTA-TATE for Diagnosis of Neuroendocrine: Differentiation in Patients With Castrate-Resistant Prostate Cancer.
    Gofrit ON; Frank S; Meirovitz A; Nechushtan H; Orevi M
    Clin Nucl Med; 2017 Jan; 42(1):1-6. PubMed ID: 27775942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous Imaging of Ga-DOTA-TATE and Lu-DOTA-TATE in Murine Models of Neuroblastoma.
    Zheng Y; Huh Y; Vetter K; Nasholm N; Gustafson C; Seo Y
    IEEE Trans Radiat Plasma Med Sci; 2023 Jan; 7(1):75-82. PubMed ID: 37635919
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of receptor affinity of natSc-DOTA-TATE versus natGa-DOTA-TATE.
    Koumarianou E; Pawlak D; Korsak A; Mikolajczak R
    Nucl Med Rev Cent East Eur; 2011; 14(2):85-9. PubMed ID: 22219148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positron emission tomographic imaging of copper 64- and gallium 68-labeled chelator conjugates of the somatostatin agonist tyr3-octreotate.
    Nedrow JR; White AG; Modi J; Nguyen K; Chang AJ; Anderson CJ
    Mol Imaging; 2014; 13():. PubMed ID: 25060207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative analysis of
    Ma G; Du J; Zhang X; Liu J; Xu X; Xu B; Guan Z
    Quant Imaging Med Surg; 2022 Apr; 12(4):2427-2440. PubMed ID: 35371938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a New Folate-Derived Ga-68-Based PET Imaging Agent.
    Brand C; Longo VA; Groaning M; Weber WA; Reiner T
    Mol Imaging Biol; 2017 Oct; 19(5):754-761. PubMed ID: 28194631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical evaluation of [
    Gaertner FC; Plum T; Kreppel B; Eppard E; Meisenheimer M; Strunk H; Bundschuh RA; Sinnes JP; Rösch F; Essler M
    Nucl Med Biol; 2019; 76-77():1-9. PubMed ID: 31520872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of a Bifunctional Cross-Bridged Chelating Agent, Peptide Conjugation, and Comparison of
    Damerow H; Wängler B; Schirrmacher R; Fricker G; Wängler C
    ChemMedChem; 2023 Jan; 18(1):e202200495. PubMed ID: 36259364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [
    Cappuzzo J; Popoola D; Prasad D; Lipinski L
    BMJ Case Rep; 2022 Apr; 15(4):. PubMed ID: 35487628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ga-68-DOTA-TATE PET/CT for discrimination of tumors of the optic pathway.
    Klingenstein A; Haug AR; Miller C; Hintschich C
    Orbit; 2015 Feb; 34(1):16-22. PubMed ID: 25264824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PET-CT imaging of pulmonary inflammation using [
    Puuvuori E; Liggieri F; Velikyan I; Chiodaroli E; Sigfridsson J; Romelin H; Ingvast S; Korsgren O; Hulsart-Billström G; Perchiazzi G; Eriksson O
    EJNMMI Res; 2022 Apr; 12(1):19. PubMed ID: 35394238
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.